Document is current
Any future updates will be listed below
-
Authors
Macak, Dominik https://orcid.org/0009-0001-7266-8515
Kanis, Philipp https://orcid.org/0000-0003-4705-4447
Riesenberg, Stephan https://orcid.org/0000-0001-8171-1717
- License Information
-
More Information
Article History
Received: 3 April 2024
Accepted: 25 November 2025
First Online: 10 December 2025
Competing interests
: The authors declare the following competing interests: Related patent application on repurposed drugs for DNA repair and increased prime editing efficiency (patent applicant: Max Planck Society; inventors: S.R., D.M., and P.K.; application number: PCT/EP2025/059927; status: pending).
